Detalhe da pesquisa
1.
Understanding the patient and family experience of nutrition and dietetic support during childhood cancer treatment.
Support Care Cancer
; 31(6): 326, 2023 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154869
2.
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(12): e29281, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596937
3.
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Nature
; 528(7582): 418-21, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26560027
4.
The Lysozyme Inhibitor Thionine Acetate Is Also an Inhibitor of the Soluble Lytic Transglycosylase Slt35 from Escherichia coli.
Molecules
; 26(14)2021 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34299465
5.
Reclassification of the Specialized Metabolite Producer Pseudomonas mesoacidophila ATCC 31433 as a Member of the Burkholderia cepacia Complex.
J Bacteriol
; 199(13)2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439036
6.
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Blood
; 125(11): 1759-67, 2015 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25645356
7.
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma.
Proc Natl Acad Sci U S A
; 108(8): 3336-41, 2011 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21289283
8.
Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program.
Pediatr Blood Cancer
; 60(11): 1860-7, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23798344
9.
Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell State.
bioRxiv
; 2023 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36909587
10.
Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state.
J Clin Invest
; 133(10)2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183825
11.
Identification of a Novel FUS/ETV4 Fusion and Comparative Analysis with Other Ewing Sarcoma Fusion Proteins.
Mol Cancer Res
; 19(11): 1795-1801, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465585
12.
Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914017
13.
Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma.
Clin Cancer Res
; 23(11): 2856-2868, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986745
14.
LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.
Cancer Cell
; 32(3): 310-323.e5, 2017 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28867147
15.
ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
Cancer Cell
; 26(5): 682-94, 2014 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25517749
16.
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.
Clin Cancer Res
; 19(22): 6173-82, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24045179
17.
The genetic landscape of high-risk neuroblastoma.
Nat Genet
; 45(3): 279-84, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23334666
18.
Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.
Cancer Res
; 72(8): 2068-78, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22350409
19.
Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.
Sci Transl Med
; 3(108): 108ra114, 2011 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22072639